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ChannelThe large-pore channels formed by the pannexin family of proteins have been implicated in many
physiological and pathophysiological functions, mainly through their ATP release function. How-
ever, a tight regulation of channel opening is necessary to modulate their function in vivo. Post-
translational modiﬁcations have been postulated as some of the regulating mechanisms for Panx1,
while Panx2 and Panx3 have not been as well characterized. Positive regulators include caspase
cleavage to open Panx1 channels in apoptotic cells, and activation by Src family kinases via ionotro-
pic receptors in neurons andmacrophages. S-nitrosylation of cysteines has been shown to both inhi-
bit and activate the Panx1 channel in different cell types. All three pannexins are N-glycosylated but
to different levels of modiﬁcation. Their diverse glycosylation appears to regulate cellular localiza-
tion, intermixing, and may restrict their ability to function as inter-cellular channels. It is clear that
our understanding of pannexin post-translational modiﬁcation and their role in channel function
regulation is still in its infancy even a decade after their discovery.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction increasing extracellular potassium concentrations [5,12,13]. There-It’s been more than a decade since the three pannexins (Panx1,
Panx2 and Panx3) were discovered based on their limited homol-
ogy to the invertebrate gap junction proteins (innexins) [1]. It
seems clear from the 300 papers on a ‘pannexin’ search in PubMed
that the main function of this branch of the gap-junction super
family is the formation of large pore, non-selective channels [2].
All Panx isoforms are tetra-spanning membrane proteins (Fig. 1).
It is thought that functional Panx1 and Panx3 channels are hexa-
meric, similar to the connexins, whereas Panx2 channels are likely
octomeric [3]. All three pannexins appear to be able to form chan-
nels capable of dye uptake [4] and more importantly, at least for
Panx1 and Panx3, they are conduits of physiologically important
molecules such as ATP [5,6], intracellular Ca++ [7,8], and even glu-
cose uptake (Panx1) [9]. Panx1 channels are proposed to have
large-pores (up to 500 pS) that allow molecules of 1.5 kDa in
size, and therefore, need to be tightly regulated so as not to com-
promise the integrity of the cell [5]. Unlike connexin hemichannels,
pannexins are not gated by extracellular calcium and can therefore
be open under physiological conditions [10]. Panx1 channels are
known to be opened at resting membrane potentials through
mechanisms involving their mechanosensitivity [5,11] and byfore, regulation of channel opening is critical to keep these large-
pore channels closed when not needed, and promptly activated
when triggered.
Panx1 has been more extensively characterized, and its function
in ATP release [5] through an interaction with purinergic receptors
[14,15] has been proposed to have a role in the propagation of cal-
cium waves. ATP and UTP released by Panx1 channels can also
have an important immune function as ‘‘ﬁnd-me’’ signals for the
clearance of apoptotic cells [16]. Panx1-mediated ATP release has
been suggested to regulate vascular tone [17] and mucociliary lung
clearance [18]. On the other hand, Panx1 channel opening can be
deleterious, contributing to cell death under ischemic conditions,
seizures [13,19], and facilitating HIV-1 viral infection [20]. Re-
cently, a functional complex of Panx1-P2X7 receptors was shown
to regulate cell death of enteric neurons in inﬂammatory bowel
diseases, resulting in abnormal gut motility [21]. Panx2 is involved
in differentiation of neurons [22], and its channel function, to-
gether with Panx1 can contribute to ischemic brain damage as evi-
dent in double (Panx1 and Panx2) constitutive knockout mice [23].
Like Panx1, Panx3 has also been shown to be a conduit for ATP re-
lease [7] and is important in the differentiation of chondrocytes [6]
and osteoblasts [7].
The pannexin isoforms have broad tissue distribution, with the
individual members having both distinct and overlapping expres-
sion patterns. Panx1 demonstrates the broadest distribution of
Fig. 1. Schematic representation of the three pannexin proteins. The pannexin family of channel-forming proteins has three members, Panx1 (A, 426 a.a.), Panx2 (B, 677 a.a.)
and Panx3 (C, 392 a.a.). All pannexins are tetra-spanning membrane proteins with two extracellular loops and intracellular amino and carboxyl termini. Colored residues
indicate sites of posttranslational modiﬁcation, including N-glycosylation, caspase cleavage, S-nitrosylation and phosphorylation.
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reported for most tissues tested, with examples that include brain,
testes, skeletal muscle, immune cells and skin [24]. Panx1 has been
found in most glutamatergic principle cells in the brain, and is
enriched in areas such as the hippocampus, amygdala, cortex,
cerebellum and retina [24–28]. By way of comparison, Panx2 is
thought to have restricted expression in the adult brain that over-
laps with that of Panx1 [29–31]. Panx2 is also reportedly present in
neural precursor (stem) cells [22]. Finally, Panx3 has its highest
expression outside of the nervous system, with transcript and pro-
tein expression being reported in chondrocytes and osteoblasts
[6,7,32], skin [11], mammary gland [32] and the male reproductive
tract [33].
All three pannexins are predominantly localized to the cell sur-
face, however, they have been reported in the cytoplasm and intra-
cellular organelles of different cell types. This targeted localization
is regulated at least in part by post-translational modiﬁcations that
may determine not only the subcellular location but also the
function of the pannexin channels at a particular site [34]. In this
review, we will present the most prominent topics related to
pannexin post-translational modiﬁcations that were discussed at
a roundtable discussion during the 2013 International Gap
Junction Conference in Charleston, SC, USA.
2. N-glycosylation
Addition of oligosaccharides to proteins at asparagine residues
is called N-glycosylation, which is a critical posttranslational mod-
iﬁcation occurring in the ER and Golgi that regulates protein fold-
ing, quality control and trafﬁcking [35]. All three pannexins are
glycoproteins containing identiﬁed N-glycosylation consensus
sites (Fig. 1). However, they present a diverse proﬁle of N-linkedglycosylation that goes from the characteristic endoplasmic reticu-
lum high mannose glycosylation (Gly1, sensitive to endoglycanase
H), to the more complex editing that happens in the Golgi (Gly2,
sensitive to N-glycosidase F) [4,11,36]. Panx2, which has been
reported to display a predominantly intracellular localization,
appears to be present in Panx2 ectopically expressing HEK 293T
cells as a Gly0 (unglycosylated) and Gly1 (high mannose glycosyl-
ated), which is consistent with the intra-cellular localization pro-
ﬁle described [3,4,22,37]. However, it should be noted that at
least in this overexpression setting and using cell surface biotinyl-
ation, a subpopulation of Panx2 was detected at the plasma mem-
brane that was capable of dye uptake [4]. The amount of Panx2
protein at the surface was doubled when co-expressed with Panx1,
indicating a potential interaction between the two pannexins [4].
Based on co-immunoprecipitation assays, the Gly0 and Gly1 forms
of Panx1 and Panx2 are found in a complex when co-expressed,
while the Gly2 form (complex glycosylation) of Panx1 does not
seem to facilitate an interaction with Panx2, and it is predomi-
nantly observed at the cell surface. The same is true for co-IPs of
Panx1 and Panx3, where the Gly0 and Gly1 forms of the proteins
are able to interact but this does not happen between the complex
Gly2 forms of the proteins [4]. This indicates that N-glycosylation
not only regulates pannexin localization in the different compart-
ments of the cell, but also the way they interact with other pann-
exin family members.
We and others have noticed that pannexin localization proﬁles
are quite diverse in different tissues and cell types. Even the
ectopic expression in different reference cell lines can look quite
different with more intracellular localization in some versus a
prominent cell surface decoration on others [38]. It has been
hypothesized that the level of glycosylation can have an impact
on the cellular location and potentially on the function of the
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tion in the endoplasmic reticulum as a calcium leak channel
[7,8], which would be consistent with the intracellular localization
that is observed in vivo, for instance in tissue sections of mouse
spleen and skin stained with Panx1 and Panx3 speciﬁc antibodies,
respectively [11].
It is possible that the complex N-glycosylated forms of the pan-
nexins would be localized preferentially at the cell surface, but the
protruding carbohydrate moieties would act as steric hindrance to
any possible docking of two pannexin hemichannels to form a gap
junction-like structure. This may explain in part why Panx1 was
initially reported to form gap junctions in paired frog oocytes, since
glycosylation modiﬁcations in frog cells are quite different from
those in mammalian cells [25]. This may also be true of any over-
expression system that can generate enough unglycosylated pan-
nexins that can trafﬁc to the cell surface (although less efﬁciently
than the glycosylated isoforms), and dock with an adjacent pann-
exin channel in a neighboring cell. Previous experiments on Panx1
expressing cells treated with tunicamycin have shown an increase
in the junctional conductance [39]. However, over-expression of N-
glycosylation deﬁcient mutants of Panx1 and 3 in HeLa cells did
not enable dye transfer between cells [38]. A caveat to this ﬁnding
is that some populations of HeLa cells have been shown to express
basal levels of Panx1 that could potentially heteromerize with the
unglycosylated mutant forms of the protein and provide the glyco-
sylation hindrance that would prevent them from docking into gap
junction-like channels.
A potential dual function of pannexins forming both single
membrane channels and functional gap junction channels would
be reminiscent of innexins, the invertebrate gap junction proteins
that in many cases are capable of that dual purpose [40]. To the
best of our knowledge, innexins, similar to connexins, have not
been shown to be modiﬁed by glycosylation. There are only three
reports of predicted glycosylation sites on Caenorhabditis elegans,
Innexin 7, 12 and 16 based on UniProtKB/SwissProt, but there is
no evidence of actual glycosylation of the innexin proteins [41].
This lack of glycosylation would in theory allow innexins to
‘‘choose’’ between forming a hemichannel for paracrine function
or a gap junction channel for inter-cellular communication.
There have been no reports so far of pannexin gap junction-like
channels in vivo, so we will have to wait until that evidence is pre-
sented, perhaps in tissues where the unglycosylated forms of the
pannexins are abundantly expressed at the cell surface. The evi-
dence up to this point, however, favors the position that the main
function of pannexins is the formation of functional single mem-
brane channels and not gap junctions [2].
3. Caspase cleavage
The release of nucleotides, such as ATP and UTP from apoptotic
cells is critical for phagocytosis [42]. Caspases play important roles,
not only in the initiation of apoptosis but also in the release of
nucleotides from apoptotic cells. Caspase cleavage of the carboxyl
terminus of Panx1 has been reported as a means for activating
channel opening. Caspase 3 and 7 cleave the human isoform of
Panx1 (hPANX1) at residues 376–379, resulting in a constitutively
active and open channel that releases ATP as a ‘ﬁnd-me’’ signal
from apoptotic immune cells for macrophage recruitment to the
site [16]. This signal is critical for the proper clearance of dead cells
by monocytes and plays an important role in normal immunity.
This gating mechanism, being irreversible and active during apop-
tosis, may be exclusive of dying immune cells. Although pannexins
have been linked to cell death events in ischemia, epileptic sei-
zures, and death of enteric neurons in colitis [13,19,21,43], it
may not necessarily be through an apoptotic event, but rather aform of necrosis activated directly or indirectly by the Panx1
channel.
Furthermore, the cleaved portion of the C-terminus of hPANX1
that is released by caspase cleavage appears to be lodged in the C-
terminal face of the pore, presumably plugging it in a ‘‘ball and
chain’’ type of fashion [44]. Sandilos et al. demonstrated that by
using proteolytic cleavage, and without additional apoptotic com-
ponents, that deleting this critical region of the C-terminus just
distal to the caspase site resulted in an activated hPANX1 channel.
To prove that the C-terminal peptide was indeed the pore blocker,
exogenous peptide added to the cell could block the cleaved chan-
nel at negative membrane potentials [44]. It remains to be seen if
this activation procedure is also present in other Panx1-expressing
cell types undergoing apoptosis, as well as in other species, since
mouse Panx1 and human PANX1 show some sequence divergence
in this area of the C-terminus. It will also be important to know
whether the other two pannexins are also potential substrates
for caspase cleavage and activation. In other systems that do not
involve activated caspases present in the cell, it would be sus-
pected that other mechanisms must be at play for relieving the
putative pore block by the C-terminus. This likely occurs in a
reversible and regulated manner to allow for controlled gating of
pannexin channels under physiological conditions, and the best
known candidates are S-nitrosylation and phosphorylation.
4. S-nitrosylation
Over the last decade or so it has become appreciated that phos-
phorylation is not the major game in town as a means of regulating
proteins through posttranslational modiﬁcations. The addition of
nitrosyl groups to speciﬁc cysteine residues (S-nitrosylation) is
now considered an important posttranslational modiﬁcation in
both physiology and disease [45]. There are several theoretical
ways in which the C-terminus could reversibly interact with the
channel pore to gate pannexins. Some examples of these are tran-
sient post-translational modiﬁcations including nitrosylation and
phosphorylation (see below). It is now well established that
numerous proteins undergo addition of nitrosyl groups to cysteine
and/or tyrosine residues as a means of regulating their function,
but also that S-nitrosylation may play a prominent role in several
neurodegenerative diseases [45].
Panx1 channels are activated under ischemic conditions that
mimic stroke [23,43,46]. Zhang and colleagues [46] reported that
blockers of nitric oxide synthase (nNOS) could prevent activation
of Panx1 during exposure to O2/glucose deprivation (OGD), assayed
as dye efﬂux from cultured neurons [47]. They further showed that
redox scavengers (DTT and GSH) were potent inhibitors of Panx1
channel opening. Together, this suggested that OGD increased NO
production and activated Panx1, probably through nitrosylation
of the protein. In these studies, the sites of nitrosylation on the
Panx1 protein were not investigated. Several subsequent studies
have looked at the impact of intracellular cysteine residues (puta-
tive sites of S-nitrosylation) on modulation of Panx1 gating.
Early studies investigating the potential role of S-nitrosylation
on Panx1 opening involved site-directed mutagenesis of cysteine
residues. Targeted cysteines were located in intracellular and
transmembrane domains, as well as in the presumed pore-forming
region. Ectopic expression of zebraﬁsh Panx1 in neuro2A (N2A)
cells with a C282W mutation (a residue in the 4th transmembrane
spanning region) lead to a channel with signiﬁcantly reduced func-
tion, characterized by the appearance of novel sub-conductance
levels, reduced current amplitudes, and a lower rate of dye efﬂux
[48]. Subsequent investigations analyzed the effects of mutating
different cysteines throughout the Panx1 protein. Notably, the
murine Panx1 C40S and C346S mutations resulted in constitutively
Table 1
Reported sites for posttranslational modiﬁcations of pannexins.
Modiﬁcation Panx1 Panx2 Panx3 References
N-glycosylation N254 N86 (predicted) N71 [4,11] (all three Panx) [36] (only Panx1)
Caspase cleavage 376–379 [16]
S-nitrosylation C40, C346 [51]
Phosphorylation Y308 (predicted) S514 [54] (Panx1) [55] (Panx2)
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[49]. On the other hand, C215S and C227S mutations (also trans-
membrane cysteines) did not alter Panx1 activation [50]. Finally,
substituting the four extracellular cysteines (C66S, C84S, C245S,
C264S) did not alter Panx1 function [50]. Together, these mutagen-
esis studies suggest that cysteines may be important for channel
regulation, but a direct role for these residues in regulating channel
gating/function under physiological (or pathophysiological) condi-
tions has not been demonstrated.
The simultaneous (or sequential) nitrosylation of multiple cys-
teine residues may be important for regulation of Panx1 functions.
For example, Lohman et al. [51], using both expression of Panx1 in
HEK 293 cells or mouse aortic endothelial cells, showed that the NO
donor, GSNO, potently inhibited ATP release through the channel.
They further demonstrated that mutation of both C40 and C346
(to alanine) was required to prevent S-nitrosylation of the channel,
where mutation of either cysteine alone could not. Interestingly, in
the studies by Bunse et al. [49,50], mutation of these two cysteines
(to serine) generated a constitutively open channel. The reasons for
these discrepancies are not clear, but could reﬂect the observations
that different cell types can express dramatically different propor-
tions of Panx1 isoforms (i.e. N-glycosylated forms, splice variants).
It is not known how post-translational modiﬁcations can interact to
alter pannexin functions. However, in all of the cysteine mutagen-
esis studies to date, a physiological stimulus has not been found
that alters Panx1 function through nitrosylation.
5. Phosphorylation
There are several predicted phosphorylation sites on S, T or Y
residues, including putative sites for PKC, PKA and CaMKII
[11,52]. Despite this, the evidence for regulation of pannexin chan-
nels by phosphorylation is currently indirect. A few studies have
shown that pharmacological antagonists of kinases can alter Panx1
activation, as well as alter the amount of phospho-Panx1 that is
present. However, a causal demonstration that a speciﬁc kinase
phosphorylates a speciﬁc residue on Panx1 has not been shown.
Two studies have suggested that Panx1 can be opened by the
activity of sarcoma (Src) family kinases (SFK) in response to iono-
tropic receptors. In Panx1 and P2X7 expressing J778 macrophages,
the SFK inhibitor, PP2 prevented activation of Panx1 by BzATP. A
targeted interfering peptide of the P2X7 receptor’s proline rich C-
terminal was also a potent blocker of Panx1 opening, presumably
through its action on preventing SFK and P2X7 interactions [53].
The second study used a similar strategy to show that the N-
methyl-D-aspartate receptor (NMDAR) in rodent hippocampal
brain slices links to Panx1 through SFKs. PP2 blocked activation
of Panx1 induced by anoxia, which is an NMDAR-dependent pro-
cess. Furthermore, an interfering peptide that comprised amino
acids 305–318 of the Panx1 C-terminal, including a presumed
SFK consensus phosphorylation site of Panx1 (Y308), was also a po-
tent blocker of anoxia-induced Panx1 opening [54]. Thus, it ap-
pears that SFKs can open Panx1 channels initiated by two
different ionotropic receptors (P2X7 and NMDAR). Direct phos-
phorylation of Panx1 (at Y308) by SFKs has not been demonstrated
and remains an open question.To the best of our knowledge the only study to date that shows
a change in phosphoserine and phosphothreonine levels of Panx1
came from the Saez group [9]. They showed an interesting series
of events where ATP acting on P2Y receptors (probably P2Y1)
opens Panx1 to potentiate muscle contraction. This was associated
with Ca2+ and glucose inﬂux through Panx1. While potentiation
was accompanied by increased phospho-Panx1 protein levels, as
assayed by Western blot on immunoprecipitated Panx1, the ki-
nases involved were not identiﬁed. Furthermore, the exact S and
T residues remain unidentiﬁed. It will be interesting to determine
if P2Y1 receptors are exerting their activation effect on Panx1
through recruitment of SFKs or another kinase.
There is currently no evidence for phosphorylation of Panx3,
though it likely occurs there. Recently, Panx2 was found to be
phosphorylated at S514 in cortical neurons (Fig. 1 and Table 1)
by a NDR (nuclear Dbf2-related) kinase, NDR1/2 [55]. Panx2 was
identiﬁed in a kinase substrate pull-down assay, along with four
other proteins. While the functional consequences of Panx2 phos-
phorylation at S514 is still unknown, it may play a role in regulated
neurite outgrowth and dendritic spine dynamics-one of the pro-
posed roles of substrates of NDR1/2.
6. Conclusions
An interesting consensus was reached during our roundtable
discussion at the International Gap Junction Conference upon
which this article is based. The group of connexin and pannexin
leaders concluded that very little is actually known about pannexin
post-translational modiﬁcations. To us, this is somewhat surprising
because the channels were ﬁrst discovered more than a decade
ago. While we do know that N-glycosylation is likely important
for trafﬁcking of Panx1, and possibly for restricting intercellular
junction formation, the majority of other potential post-transla-
tional modiﬁcations are poorly understood. This is perhaps best
emphasized by the apparently conﬂicting outcome of cysteine
modiﬁcations reported by several groups. Thus, the challenge of
the next decade or so is to precisely deﬁne the functional outcome
of pannexin post-translational modiﬁcations under physiological
and pathophysiological conditions. One area of initial focus may
be on the modiﬁcation of the Panx1 C-terminal region, which many
groups have suggested is critical in gating the channels.References
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